GHB Analog-Containing Product Demand High, NEJM Researchers Report
This article was originally published in The Tan Sheet
Executive Summary
Extensive industrial use of the GHB analog 1,4-butanediol (BD), in conjunction with the flexibility and anonymity of Internet marketing, "ensures a continued supply that is almost impossible to regulate," researchers say in the Jan. 11 New England Journal of Medicine.
You may also be interested in...
Internet GHB Bust Could Lead To Future Web Shakedowns – DEA
Leads and information obtained from a recent "takedown" of online gamma hydroxybutyrate (GHB) traffickers could result in future investigation and arrests, the Drug Enforcement Administration stated
Internal Analgesic Drugs Most Common OTCs Recalled In 2000
Nine OTC internal analgesics were recalled last year, the most of any category of over-the-counter drugs, based on a compilation of FDA's weekly reports on company-initiated recalls and court actions.
NIDA Club Drug Research Funding To Jump 40%, Education Effort Underway
The National Institute on Drug Abuse is accelerating its research efforts on the risks of "club drugs," including methamphetamine and GHB, through a 40% funding increase. The institute will now dedicate $54 mil. to study the abuse of these substances.